Sofgen Pharma S.A. PROCF
At closeNov 11, 2026, 4:00 PM EST
- YTD
- -50.00%
- 1 year
- -58.99%
PROCF free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-14,783,000 USD
FY 2022 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | -14,783,000 | -28,355,000 | -208.92% |
| FY 2021 | 2021-12-31 | 13,572,000 | -40,062,000 | -74.70% |
| FY 2020 | 2020-12-31 | 53,634,000 | -3,126,000 | -5.51% |
| FY 2019 | 2019-12-31 | 56,760,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-09-05T14:31:35.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.